Aditxt, Inc. Common Stock
Symbol: ADTX (NASDAQ)
1.20
▼ (-5.16%) -0.065
Company Description:
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
Key Stats
- Today's Open: $1.26
- Today's High: $1.284
- Today's Low: $1.175
- Today's Volume: 327.77K
- Yesterday Close: $1.26
- Yesterday High: $1.31
- Yesterday Low: $1.23
- Yesterday Volume: 1.53M
- Last Min Volume: 2
- Last Min High: $1.195
- Last Min Low: $1.195
- Last Min VWAP: $1.195
Company Profile
- Name: Aditxt, Inc. Common Stock
- Website: https://www.aditxt.com
- Listed Date: 2020-06-30
- Location: RICHMOND, VA
- Market Status: Active
- CIK Number: 0001726711
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $2.89M
- Round Lot: 100
- Outstanding Shares: 2.43M
- Asset Type: CS
RECENT FILINGS FOR ADTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-24 | 8-K | View |
| 2025-07-21 | 8-K | View |
| 2025-07-10 | 8-K | View |
| 2025-07-01 | 8-K | View |
| 2025-06-30 | EFFECT | View |
| 2025-06-30 | 424B3 | View |
| 2025-06-25 | 8-K | View |
| 2025-06-20 | S-1 | View |
| 2025-06-09 | 3 | View |
| 2025-06-09 | 8-K | View |
| 2025-06-02 | 8-K | View |
| 2025-05-27 | 8-K | View |
| 2025-05-19 | 8-K | View |
| 2025-05-19 | 8-K/A | View |
| 2025-05-19 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-15 | 8-K | View |
| 2025-05-05 | 8-K | View |
| 2025-04-25 | 8-K | View |
| 2025-04-22 | 8-K | View |
Latest News on ADTX